Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Acellular Dermal Matrix Investigation in Breast Reconstruction

NCT: NCT06456554 · RECRUITING

NCT IDNCT06456554
StatusRECRUITING
Start Date2024-11-22
Completion2027-12

Brief Summary

Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.

Frequently Asked Questions

What is Acellular Dermal Matrix Investigation in Breast Reconstruction?

Acellular Dermal Matrix Investigation in Breast Reconstruction is a clinical trial registered under NCT06456554. Current status: RECRUITING.

What is the status of NCT06456554?

The current status of NCT06456554 (Acellular Dermal Matrix Investigation in Breast Reconstruction) is: RECRUITING.

When did Acellular Dermal Matrix Investigation in Breast Reconstruction start?

Acellular Dermal Matrix Investigation in Breast Reconstruction started on 2024-11-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑